REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20
Event to include clinical program overview and perspectives from leading retina specialists ahead of topline pivotal data readout anticipated in 4Q 2026 ROCKVILLE, Md., Oct. 12, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will host an investor event at 1:00 p.m....
Covered in this story
Analyst targets on Advanced Micro Devices
- Rosenblatt Securities: $608 → $665 by Oct 2027 · Buy via Stocktwits
- UBS: $608 → $700 by Oct 2027 · Buy via Stocktwits
- Mizuho: $649 → $705 by Oct 2027 · outperform via FXLeaders
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $AMD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Advanced Micro Devices →Dalsna Finance is currently tracking 53 stories mentioning Advanced Micro Devices, the earliest published 4 Aug 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.